DFS vs PTHS
DFS (DFS) versus Pelthos Therapeutics Inc. (PTHS) — a side-by-side from cached financials, not a winner call.
DFS (DFS) common stock.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
DFS does not have a complete income-statement cache yet.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
PTHS currently screens at market cap $94.7M.
Not investment advice. Open the DFS and PTHS stock pages for the full models.
Not investment advice.